Literature DB >> 22775001

Polymorphisms in Fas gene is associated with HIV-related lipoatrophy in Thai patients.

Sirirat Likanonsakul1, Tippawan Rattanatham, Siriluk Feangvad, Sumonmal Uttayamakul, Wisit Prasithsirikul, Somkid Srisopha, Ravee Nitiyanontakij, Pimrapat Tengtrakulcharoen, Maciej Tarkowski, Agostino Riva, Emi E Nakayama, Tatsuo Shioda.   

Abstract

The present study aimed to evaluate the role of genetic polymorphisms in the emergence of lipoatrophy or lipodystrophy in HIV-infected patients with antiretroviral therapy (ART) in Thailand. Position 455 upstream of the Apolipoprotein C3 gene (ApoC3 T-455C, rs2854116), codon 64 of the Beta3 adrenergic receptor gene (ARβ3 Tcod64C, rs4994), and position 670 upstream of the Fas gene (Fas A-670G, rs1800682) were genotyped in 829 HIV-infected Thai patients who had started ART. Crude and adjusted incidence rate ratios (IRR) were calculated using Poisson regression. The serum levels of cholesterol, triglycerides, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) were also analyzed. Multivariate analysis revealed an association between the Fas -670AA genotype, but not the ApoC3 -455 or ARβ3 cod64 genotypes, with the incidence of lipoatrophy after adjusting for gender and stavudine (d4T)-containing regimens (IRR=1.72, 95% CI=1.20-2.45, p=0.003). However, ApoC3 -455C homozygous patients showed elevated serum levels of triglycerides, while this genotype did not affect serum total cholesterol, HDL, or LDL levels in patients with lipoatrophy or lipodystrophy. In contrast, the ARβ3 cod64 genotype did not show any significant association with the serum levels of cholesterol, triglycerides, HDL, or LDL. In conclusion, Fas -670AA affected the incidence of lipoatrophy in HIV-1-infected Thai patients, while the ApoC3 -455C allele affected the serum levels of triglycerides. These results confirmed the role of genetics in the development of ART-related metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22775001      PMCID: PMC3537319          DOI: 10.1089/AID.2012.0114

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  50 in total

Review 1.  HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management.

Authors:  Andrew Carr
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

2.  Improvements in cheek volume in lipoatrophic individuals switching away from thymidine nucleoside reverse transcriptase inhibitors.

Authors:  P Benn; V Sauret-Jackson; J Cartledge; C Ruff; C A Sabin; G Moyle; A Linney; G Reilly; S G Edwards
Journal:  HIV Med       Date:  2009-03-11       Impact factor: 3.180

3.  Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

Authors:  G Behrens; A Dejam; H Schmidt; H J Balks; G Brabant; T Körner; M Stoll; R E Schmidt
Journal:  AIDS       Date:  1999-07-09       Impact factor: 4.177

4.  Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients.

Authors:  Q R Huang; V Danis; M Lassere; J Edmonds; N Manolios
Journal:  Rheumatology (Oxford)       Date:  1999-07       Impact factor: 7.580

5.  Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

Authors:  C S Wang; W J McConathy; H U Kloer; P Alaupovic
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.

Authors:  M Sievers; U A Walker; K Sevastianova; B Setzer; D Wågsäter; P Eriksson; H Yki-Järvinen; J Sutinen
Journal:  J Infect Dis       Date:  2009-07-15       Impact factor: 5.226

Review 7.  Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy.

Authors:  Eric Bonnet; Annelise Genoux; Jacques Bernard; Josette Fauvel; Patrice Massip; Bertrand Perret
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

8.  Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.

Authors:  Michael P Dubé; Lauren Komarow; Kathleen Mulligan; Steven K Grinspoon; Robert A Parker; Gregory K Robbins; Ronenn Roubenoff; Pablo Tebas
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-15       Impact factor: 3.731

9.  Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy.

Authors:  Barbara Zanone Poma; Agostino Riva; Milena Nasi; Paola Cicconi; Valentina Broggini; Alessandro Cozzi Lepri; Daniela Mologni; Francesco Mazzotta; Antonella D'Arminio Monforte; Cristina Mussini; Andrea Cossarizza; Massimo Galli
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

10.  A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.

Authors:  Satomi Kanemitsu; Kenji Ihara; Ahmed Saifddin; Takeshi Otsuka; Tsutomu Takeuchi; Jun Nagayama; Michihiko Kuwano; Toshiro Hara
Journal:  J Rheumatol       Date:  2002-06       Impact factor: 4.666

View more
  4 in total

1.  Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population.

Authors:  Min-Rui Li; Sheng-Hong Zhang; Kang Chao; Xian-Hua Liao; Jia-Yan Yao; Min-Hu Chen; Bi-Hui Zhong
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

2.  Association of the polymorphisms of the genes APOC3 (rs2854116), ESR2 (rs3020450), HFE (rs1799945), MMP1 (rs1799750) and PPARG (rs1801282) with lipodystrophy in people living with HIV on antiretroviral therapy: a systematic review.

Authors:  Andreia Soares da Silva; Tatiana Lins Carvalho; Kleyton Palmeira do Ó; Débora Nascimento da Nóbrega; Roberta Dos Santos Souza; Victor Fernando da Silva Lima; Isabela Cristina Cordeiro Farias; Taciana Furtado de Mendonça Belmont; Maria do Socorro de Mendonça Cavalcanti; Demócrito de Barros Miranda-Filho
Journal:  Mol Biol Rep       Date:  2020-04-22       Impact factor: 2.316

Review 3.  HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settings.

Authors:  Julia L Finkelstein; Pooja Gala; Rosemary Rochford; Marshall J Glesby; Saurabh Mehta
Journal:  J Int AIDS Soc       Date:  2015-01-15       Impact factor: 5.396

4.  Genome-Wide Association Study of HIV-Related Lipoatrophy in Thai Patients: Association of a DLGAP1 Polymorphism with Fat Loss.

Authors:  Sumonmal Uttayamakul; Tiphaine Oudot-Mellakh; Emi E Nakayama; Pimrapat Tengtrakulcharoen; Julien Guergnon; Jean-Francois Delfraissy; Srisin Khusmith; Chariya Sangsajja; Sirirat Likanonsakul; Ioannis Theodorou; Tatsuo Shioda
Journal:  AIDS Res Hum Retroviruses       Date:  2015-06-15       Impact factor: 2.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.